NeuroAIDS in Africa

Journal of NeuroVirology - Tập 16 - Trang 189-202 - 2010
Kevin Robertson1, Jeff Liner1, James Hakim2, Jean-Louis Sankalé3, Igor Grant4, Scott Letendre4, David Clifford5, Amadou Gallo Diop6, Assan Jaye7, Georgette Kanmogne8, Alfred Njamnshi9, T. Dianne Langford10, Tufa Gemechu Weyessa11, Charles Wood12, Mwanza Banda13, Mina Hosseinipour14, Ned Sacktor15, Noeline Nakasuja16, Paul Bangirana16, Robert Paul17, John Joska18, Joseph Wong19, Michael Boivin20, Penny Holding21, Betsy Kammerer22, Annelies Van Rie23, Prudence Ive24, Avindra Nath25, Kathy Lawler26, Clement Adebamowo27, Walter Royal28, Jeymohan Joseph29
1Department of Neurology, University of North Carolina, Chapel Hill, USA
2University of Zimbabwe, Harare, Zimbabwe
3Globomics, LLC, Decatur, USA
4University of California, San Diego, La Jolla, USA
5Washington University School of Medicine, St. Louis, USA.
6University of Dakar, Dakar, Senegal
7Medical Research Council Laboratories, Gambia Unit, Banjul, The Gambia
8University of Nebraska Medical Center, Omaha, USA
9University of Yaoundé, Yaoundé, Cameroon
10Temple University School of Medicine, Philadelphia, USA
11Addis Ababa University, Addis Ababa, Ethiopia
12Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, USA
13University Teaching Hospital, Lusaka, Zambia
14UNC Project, Lilongwe, Malawi
15Johns Hopkins Bayview Medical Center, Johns Hopkins University, Baltimore, USA
16Makerere University, Kampala, Uganda
17University of Missouri, St. Louis, Chesterfield, USA
18University of Cape Town, Cape Town, South Africa
19University of California San Francisco, San Francisco, USA
20Michigan State University, East Lansing, USA
21Case Western Reserve University, Cleveland USA
22Children’s Hospital, Boston/Harvard Medical School, Newton, USA
23University of North Carolina at Chapel Hill, Chapel Hill, USA
24Clinical HIV Research Unit, Helen Joseph Hospital, Gauteng, South Africa
25Johns Hopkins University, Baltimore, USA
26University of Pennsylvania, Philadelphia, USA
27Office of Strategic Information and Research, Institute of Human Virology, Abuja, Nigeria
28University of Maryland School of Medicine, Baltimore, USA
29HIV Pathogenesis, Neuropsychiatry and Treatment Branch, Center for Mental Health Research on AIDS, National Institute of Mental Health, National Institutes of Health, Bethesda, USA

Tóm tắt

In July 2009, the Center for Mental Health Research on AIDS at the National Institute of Mental Health organized and supported the meeting “NeuroAIDS in Africa.” This meeting was held in Cape Town, South Africa, and was affiliated with the 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Presentations began with an overview of the epidemiology of HIV in sub-Saharan Africa, the molecular epidemiology of HIV, HIV-associated neurocognitive disorders (HANDs), and HAND treatment. These introductory talks were followed by presentations on HAND research and clinical care in Botswana, Cameroon, Ethiopia, The Gambia, Kenya, Malawi, Nigeria, Senegal, South Africa, Uganda, and Zambia. Topics discussed included best practices for assessing neurocognitive disorders, patterns of central nervous system (CNS) involvement in the region, subtype-associated risk for HAND, pediatric HIV assessments and neurodevelopment, HIV-associated CNS opportunistic infections and immune reconstitution syndrome, the evolving changes in treatment implementation, and various opportunities and strategies for NeuroAIDS research and capacity building in the region.

Từ khóa


Tài liệu tham khảo

Abubakar A, Holding P, van Baar A, Newton CR, van de Vijver FJ (2008). Monitoring psychomotor development in a resource-limited setting: an evaluation of the Kilifi Developmental Inventory. Ann Trop Paediatr 28: 217–226.

Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69: 1789–1799.

Clifford DB, Mitike MT, Mekonnen Y, Zhang J, Zenebe G, Melaku Z, Zewde A, Gessesse N, Wolday D, Messele T, Teshome M, Evans S (2007). Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia. J NeuroVirol 13: 67–72.

Descamps D, Collin G, Letourneur F, Apetrei C, Damond F, Loussert-Ajaka I, Simon F, Saragosti S, Brun-Vezinet F (1997). Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses. J Virol 71: 8893–8898.

Diamond GW, Kaufman J, Belman AL, Cohen L, Cohen HJ, Rubinstein A (1987). Characterization of cognitive functioning in a subgroup of children with congenital HIV infection. Arch Clin Neuropsychol 2: 245–256.

Epstein LG, Sharer LR, Oleske JM, Connor EM, Goudsmit J, Bagdon L, Robert-Guroff M, Koenigsberger MR (1986). Neurologic manifestations of human immunodeficiency virus infection in children. Pediatrics 78: 678–687.

Gupta JD, Satishchandra P, Gopukumar K, Wilkie F, Waldrop-Valverde D, Ellis R, Ownby R, Subbakrishna DK, Desai A, Kamat A, Ravi V, Rao BS, Satish KS, Kumar M (2007). Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India. J NeuroVirol 13: 195–202.

Hemelaar J, Gouws E, Ghys PD, Osmanov S (2006). Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 20: W13-W23.

Hoelscher M, Dowling WE, Sanders-Buell E, Carr JK, Harris ME, Thomschke A, Robb ML, Birx DL, McCutchan FE (2002). Detection of HIV-1 subtypes, recombinants, and dual infections in east Africa by a multi-region hybridization assay. AIDS 16: 2055–2064.

Kanki PJ, Hamel DJ, Sankale JL, Hsieh C, Thior I, Barin F, Woodcock SA, Gueye-Ndiaye A, Zhang E, Montano M, Siby T, Marlink R, I ND, Essex ME, S MB (1999). Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 179: 68–73.

Laeyendecker O, Li X, Arroyo M, McCutchan F, Gray R, Wawer M, Serwadda D, Nalugoda F, Kigozi G, Quinn T, and Rakai Health Science Program (2006). 13th Conference on Retroviruses and Opportunistic Infections; February 5–February 8, 2006; Denver, CO.

LANL (2010). The circulating recombinant forms (CRFs). In: HIV Sequence Database. Los Alamos, NM: Los Alamos National Laboratory.

Miller RF, Isaacson PG, Hall-Craggs M, Lucas S, Gray F, Scaravilli F, An SF (2004). Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART. Acta Neuropathol 108: 17–23.

Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F (2004). Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 364: 1236–1243.

Poveda E, de Mendoza C, Parkin N, Choe S, Garcia-Gasco P, Corral A, Soriano V (2008). Evidence for different susceptibility to tipranavir and darunavir in patients infected with distinct HIV-1 subtypes. AIDS 22: 611–616.

Ren J, Bird LE, Chamberlain PP, Stewart-Jones GB, Stuart DI, Stammers DK (2002). Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors. Proc Natl Acad Sci USA 99: 14410–14415.

Riedel DJ, Pardo CA, McArthur J, Nath A (2006). Therapy insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome. Nat Clin Pract Neurol 2: 557–565.

Shelburne SA, Montes M, Hamill RJ (2006). Immune reconstitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother 57: 167–170.

Tscherning C, Alaeus A, Fredriksson R, Bjorndal A, Deng H, Littman DR, Fenyo EM, Albert J (1998). Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 241: 181–188.

Van Rie A, Dow A, Mupuala A, Stewart P (2009). Neuro-developmental trajectory of HIV-infected children accessing care in Kinshasa, Democratic Republic of Congo. J Acquir Immune Defic Syndr 52: 636–642.

Van Rie A, Mupuala A, Dow A (2008). Impact of the HIV/ AIDS epidemic on the neurodevelopment of preschoolaged children in Kinshasa, Democratic Republic of the Congo. Pediatrics 122: e123-e128.

Vasan A, Renjifo B, Hertzmark E, Chaplin B, Msamanga G, Essex M, Fawzi W, Hunter D (2006). Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. Clin Infect Dis 42: 843–852.

Venkataramana A, Pardo CA, McArthur JC, Kerr DA, Irani DN, Griffin JW, Burger P, Reich DS, Calabresi PA, Nath A (2006). Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology 67: 383–388.

WHO/UNAIDS (2008). Report on the Global AIDS Epidemic. Epub: http://www.unaids.org/en/KnowledgeCentre/ HIVData/GlobalReport/2008/2008_Global_report.asp

Williams PL, Marino M, Malee K, Brogly S, Hughes MD, Mofenson LM (2010). Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants. Pediatrics 125: e250-e260.

Thông tin
Thông tin xuất bản

Journal of NeuroVirology

Tập 16

189-202

Thông tin tác giả